DDI-DrugBank.d604.s0 >> Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and reserpine. >> 0-10,66-77,80-86,89-102,109-117
DDI-DrugBank.d604.s1 >> Peripheral Neuropathy: Medications known to be associated with peripheral neuropathy should be used with caution in patients receiving thalidomide. >> 135-145
DDI-DrugBank.d604.s2 >> Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. >> 5-18,74-86,92-108,173-193,210-226
DDI-DrugBank.d604.s3 >> The results were similar with and without coadministration of thalidomide 200 mg/day to steady-state levels. >> 62-72
DDI-DrugBank.d604.s4 >> Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St. >> 14-24,70-92,114-136,139-150,153-161,164-174,177-184,187-195,198-206,209-221
DDI-DrugBank.d604.s5 >> John's Wort with hormonal contraceptive agents may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies. >> 0-10,17-45
DDI-DrugBank.d604.s6 >> Therefore, women requiring treatment with one or more of these drugs must use two OTHER effective or highly effective methods of contraception or abstain from heterosexual sexual contact while taking thalidomide. >> 200-210
